MERS-CoV Infection tReated With A Combination of Lopinavir /Ritonavir and Interferon Beta-1b: a Multicenter, Placebo-controlled, Double-blind Randomized Trial
Phase of Trial: Phase II/III
Latest Information Update: 09 Nov 2017
At a glance
- Drugs Interferon beta-1b (Primary) ; Lopinavir/ritonavir (Primary)
- Indications Middle East respiratory syndrome coronavirus
- Focus Therapeutic Use
- Acronyms MIRACLE
- 02 Nov 2017 Planned number of patients changed from 80 to 194.
- 28 Nov 2016 Status changed from not yet recruiting to recruiting.
- 30 Jul 2016 New trial record